학술논문
Indacaterol/glycopyrronium (IND/GLY) reduces the risk of clinically important deterioration (CID) in patients with moderate COPD: Results from the CRYSTAL study
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
13993003